Coffee bioequivalence trial for healthy adults
Part of Heart & circulation clinical trials.
This trial tests whether a new coffee product works the same way in your body as a standard coffee. It is for healthy adults who do not have any medical conditions or take medications that could affect the results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old
- You are a healthy man or a woman with regular periods
- You have a body mass index (BMI) between 18.5 and 30
- You do not have any ongoing medical conditions like high blood pressure, diabetes, heart disease, or stomach problems
- You don't smoke, vape, or drink more than 14 units of alcohol per week
- You are not pregnant, planning pregnancy, or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how coffee affects people who do intense exercise, and how their bodies process caffeine. It may help understand if coffee can improve exercise performance or recovery.
This trial tests if a special coffee drink with agave fiber can help control appetite in adults with obesity. You would drink the beverage daily and report how hungry you feel.
This study looks at how drinking coffee changes the levels of certain natural chemicals (called metabolites) in your body. It aims to understand how your body processes coffee and why it might be healthy.
This study looks at how coffee affects your body's energy use (metabolic rate). It may help researchers understand the effects of coffee on healthy adults.
This study looks at how coffee affects your body's energy use and how quickly you process caffeine. It may help explain why coffee affects people differently.
This early-phase study tests whether a coffee-related approach can change gut bacteria and blood “metabolites” after treatment for stage I–III colon or rectal cancer. The goal is to learn if these changes could help improve health after standard cancer treatment.
Hear when a new Bioequivalence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.